Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine infusion to improve remifentanil-induced hyperalgesia during laparoscopic cholecystectomy
ChiCTR2500110594Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in cholecystitis, cholelithiasis and Remifentanil-induced hyperalgesia (RIH) (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Visual analogue scale (pain intensity). Planned start Oct 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
cholecystitischolelithiasisRemifentanil-induced hyperalgesia (RIH)
Beyond the preview
Go deeper on ChiCTR2500110594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110594.